FDA will likely pull epinephrine inhalers (Primatene Mist, etc) off the market
FDA will likely pull epinephrine inhalers (Primatene Mist, etc) off the market.
FDA advisors now say that OTC epinephrine inhalers DON'T offer an important health benefit...and SHOULDN'T be exempt from the ban on chlorofluorocarbon (CFC) propellants.
Wyeth is trying to reformulate Primatene Mist. But it could take 5 years for the new version to be tested and approved.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote